Abstract
Chemical manufacturers and some US lawmakers are demanding dramatic reforms and increased external scrutiny of the Environmental Protection Agency's (EPA's) chemical carcinogenicity and toxicity assessment programme, known as the Integrated Risk Information System (IRIS), but these would hinder identification of chemical threats to public health, IRIS proponents told The Lancet Oncology.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
